Skip to main content
. 2022 Mar 2;37(5):823–831. doi: 10.1111/jgh.15796

Figure 1.

Figure 1

Antibody formation against SARS‐CoV‐2 in COVID‐19 patients in SIM01 and control groups. Inline graphic, SIM01; Inline graphic, Controls. [Color figure can be viewed at wileyonlinelibrary.com]